Harbinger&s;s mission is to be a value-added venture investor in the core technologies that will enhance the productivity and experience at
Business Model:
Revenue: $14.7M
Employees: 2-10
Address: 3 Results Way
City: Cupertino
State: CA
Zip: 95014
Country: US
Harbinger&s;s mission is to be a value-added venture investor in the core technologies that will enhance the productivity and experience at the workplace or at home. Leveraging the MiTAC-SYNNEX Group&s;s strong financial backing and web of networks, they strive to create synergy and forge strategic relationships among their investee companies and the Group&s;s affiliated companies at every opportunity. Welcoming challenge, Harbinger will continue to be a forerunner in the technologies that will change the communications and computing networks of tomorrow while generating tangible results and real value for both its investees and investors.
Contact Phone:
+14088613683
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2006 | Splashtop | Series A | 10.5M |
1/2019 | Vinebox | Series A | 0 |
11/2017 | Cora | Series A | 6M |
1/2004 | Optovue | Series A | - |
3/2007 | Optovue | Series B | 0 |
1/2008 | Crown Bioscience | Venture Round | - |
8/2005 | VeriSilicon Holdings | Series B | 14.8M |
3/2003 | VeriSilicon Holdings | Series A | 6M |
12/2002 | Ortega InfoSystems | Series C | 11.8M |
12/2007 | Babycare | Venture Round | 1M |
12/2005 | Centrality Communications | Series D | 20M |
1/2005 | A10 Networks | Series A | 6M |
10/2006 | AutoNavi | Series A | 40M |
9/2008 | Envivio | Venture Round | 0 |
12/2009 | Envivio | Debt | 1M |
3/2001 | SiberCore Technologies | Series C | 0 |
1/2005 | Gammastar Medical Group | Series A | 8.7M |
5/2006 | Cardiva Medical | Series C | 0 |
6/2005 | Cardiva Medical | Series B | 0 |
9/2005 | Paxera | Series A | 5.4M |
6/2004 | Continuous Computing | Venture Round | 15M |
9/2007 | Quellan | Series C | 20M |
1/2023 | Profet AI | Series A | 5.6M |
5/2003 | Cardiva Medical | Series A | 7M |
4/2019 | Cora | Series A | 0 |
4/2008 | Quintic | Series B | - |
11/2003 | Cardiva Medical | Series A | 10.5M |
7/2008 | A10 Networks | Series C | 0 |
8/2007 | Zhanzuo | Series B | 8M |
2/2002 | Silicon Bandwidth | Series B | 0 |
5/2004 | Tasman Networks | Venture Round | 14.4M |
7/2003 | Plaxo | Series B | 8.5M |
5/2002 | Envivio | Series B | 0 |
9/2014 | Eureka Therapeutics | Series C | 0 |
1/2011 | Coda Automotive | Series D | 0 |
4/2019 | Cora | Series A | 0 |
1/2019 | Vinebox | Series A | 0 |
11/2017 | Cora | Series A | 0 |
9/2014 | Eureka Therapeutics | Series C | 0 |
1/2011 | Coda Automotive | Series D | 0 |
12/2009 | Envivio | Debt Financing | 0 |
9/2008 | Envivio | Venture Round | 0 |
7/2008 | A10 Networks | Series C | 0 |
4/2008 | Quintic | Series B | - |
1/2008 | Crown Bioscience | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|